Peter W Groeneveld1,2,3,4, Elina L Medvedeva1, Lorrie Walker1, Andrea G Segal1,2,4, Diane M Richardson5, Andrew J Epstein1,3,6. 1. Department of Veterans Affairs' Center for Health Equity Research and Promotion, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania. 2. Division of General Internal Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia. 3. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia. 4. Cardiovascular Outcomes, Quality, and Evaluative Research Center, University of Pennsylvania, Philadelphia. 5. Jazz Pharmaceuticals Inc, Philadelphia, Pennsylvania. 6. Medicus Economics, LLC, Milton, Massachusetts.
Abstract
Importance: The Department of Veterans Affairs (VA) operates a nationwide system of hospitals and hospital-affiliated clinics, providing health care to more than 2 million veterans with cardiovascular disease. While data permitting hospital comparisons of the outcomes of acute cardiovascular care (eg, myocardial infarction) are publicly available, little is known about variation across VA medical centers (VAMCs) in outcomes of care for populations of patients with chronic, high-risk cardiovascular conditions. Objective: To determine whether there are substantial differences in cardiovascular outcomes across VAMCs. Design, Setting, and Participants: Retrospective cohort study comprising 138 VA hospitals and each hospital's affiliated outpatient clinics. Patients were identified who received VA inpatient or outpatient care between 2010 and 2014. Separate cohorts were constructed for patients diagnosed as having either ischemic heart disease (IHD) or chronic heart failure (CHF). The data were analyzed between June 24, 2015, and November 21, 2017. Exposures: Hierarchical linear models with VAMC-level random effects were estimated to compare risk-standardized mortality rates for IHD and for CHF across 138 VAMCs. Mortality estimates were risk standardized using a wide array of patient-level covariates derived from both VA and Medicare health care encounters. Main Outcomes and Measures: All-cause mortality. Results: The cohorts comprised 930 079 veterans with IHD and 348 015 veterans with CHF; both cohorts had a mean age of 77 years and were predominantly white (IHD, n = 822 665 [89%] and CHF, n = 287 871 [83%]) and male (IHD, n = 916 684 [99%] and CHF n = 341 352 [98%]). The VA-wide crude annual mortality rate was 7.4% for IHD and 14.5% for CHF. For IHD, VAMCs' risk-standardized mortality varied from 5.5% (95% CI, 5.2%-5.7%) to 9.4% (95% CI, 9.0%-9.9%) (P < .001 for the difference). For CHF, VAMCs' risk-standardized mortality varied from 11.1% (95% CI, 10.3%-12.1%) to 18.9% (95% CI, 18.3%-19.5%) (P < .001 for the difference). Twenty-nine VAMCs had IHD mortality rates that significantly exceeded the national mean, while 35 VAMCs had CHF mortality rates that significantly exceeded the national mean. Veterans Affairs medical centers' mortality rates among their IHD and CHF populations were not associated with 30-day mortality rates for myocardial infarction (R2 = 0.01; P = .35) and weakly associated with hospitalized heart failure 30-day mortality (R2 = 0.16; P < .001) and the VA's star rating system (R2 = 0.06; P = .005). Conclusions and Relevance: Risk-standardized mortality rates for IHD and CHF varied widely across the VA health system, and this variation was not well explained by differences in demographics or comorbidities. This variation may signal substantial differences in the quality of cardiovascular care between VAMCs.
Importance: The Department of Veterans Affairs (VA) operates a nationwide system of hospitals and hospital-affiliated clinics, providing health care to more than 2 million veterans with cardiovascular disease. While data permitting hospital comparisons of the outcomes of acute cardiovascular care (eg, myocardial infarction) are publicly available, little is known about variation across VA medical centers (VAMCs) in outcomes of care for populations of patients with chronic, high-risk cardiovascular conditions. Objective: To determine whether there are substantial differences in cardiovascular outcomes across VAMCs. Design, Setting, and Participants: Retrospective cohort study comprising 138 VA hospitals and each hospital's affiliated outpatient clinics. Patients were identified who received VA inpatient or outpatient care between 2010 and 2014. Separate cohorts were constructed for patients diagnosed as having either ischemic heart disease (IHD) or chronic heart failure (CHF). The data were analyzed between June 24, 2015, and November 21, 2017. Exposures: Hierarchical linear models with VAMC-level random effects were estimated to compare risk-standardized mortality rates for IHD and for CHF across 138 VAMCs. Mortality estimates were risk standardized using a wide array of patient-level covariates derived from both VA and Medicare health care encounters. Main Outcomes and Measures: All-cause mortality. Results: The cohorts comprised 930 079 veterans with IHD and 348 015 veterans with CHF; both cohorts had a mean age of 77 years and were predominantly white (IHD, n = 822 665 [89%] and CHF, n = 287 871 [83%]) and male (IHD, n = 916 684 [99%] and CHF n = 341 352 [98%]). The VA-wide crude annual mortality rate was 7.4% for IHD and 14.5% for CHF. For IHD, VAMCs' risk-standardized mortality varied from 5.5% (95% CI, 5.2%-5.7%) to 9.4% (95% CI, 9.0%-9.9%) (P < .001 for the difference). For CHF, VAMCs' risk-standardized mortality varied from 11.1% (95% CI, 10.3%-12.1%) to 18.9% (95% CI, 18.3%-19.5%) (P < .001 for the difference). Twenty-nine VAMCs had IHD mortality rates that significantly exceeded the national mean, while 35 VAMCs had CHF mortality rates that significantly exceeded the national mean. Veterans Affairs medical centers' mortality rates among their IHD and CHF populations were not associated with 30-day mortality rates for myocardial infarction (R2 = 0.01; P = .35) and weakly associated with hospitalized heart failure 30-day mortality (R2 = 0.16; P < .001) and the VA's star rating system (R2 = 0.06; P = .005). Conclusions and Relevance: Risk-standardized mortality rates for IHD and CHF varied widely across the VA health system, and this variation was not well explained by differences in demographics or comorbidities. This variation may signal substantial differences in the quality of cardiovascular care between VAMCs.
Authors: Amal N Trivedi; Sierra Matula; Isomi Miake-Lye; Peter A Glassman; Paul Shekelle; Steven Asch Journal: Med Care Date: 2011-01 Impact factor: 2.983
Authors: Harlan M Krumholz; Zhenqiu Lin; Elizabeth E Drye; Mayur M Desai; Lein F Han; Michael T Rapp; Jennifer A Mattera; Sharon-Lise T Normand Journal: Circ Cardiovasc Qual Outcomes Date: 2011-03
Authors: P Michael Ho; Stacie A Luther; Frederick A Masoudi; Indra Gupta; Elliott Lowy; Charles Maynard; Anne E Sales; Eric D Peterson; Stephan D Fihn; John S Rumsfeld Journal: Am Heart J Date: 2007-09 Impact factor: 4.749
Authors: C M Ashton; N J Petersen; J Souchek; T J Menke; H J Yu; K Pietz; M L Eigenbrodt; G Barbour; K W Kizer; N P Wray Journal: N Engl J Med Date: 1999-01-07 Impact factor: 91.245
Authors: Jenice Guzman-Clark; Bonnie J Wakefield; Melissa M Farmer; Maria Yefimova; Benjamin Viernes; Martin L Lee; Theodore J Hahn Journal: Telemed J E Health Date: 2020-12-03 Impact factor: 3.536
Authors: Jenice Guzman-Clark; Melissa M Farmer; Bonnie J Wakefield; Benjamin Viernes; Maria Yefimova; Martin L Lee; Theodore J Hahn Journal: Nurs Outlook Date: 2020-12-02 Impact factor: 3.250
Authors: Andrea G Segal; Keri L Rodriguez; Judy A Shea; Kristina L Hruska; Lorrie Walker; Peter W Groeneveld Journal: J Am Heart Assoc Date: 2019-05-07 Impact factor: 5.501
Authors: Peter W Groeneveld; Elina L Medvedeva; Lorrie Walker; Andrea G Segal; Diane M Menno; Andrew J Epstein Journal: JAMA Netw Open Date: 2019-07-03
Authors: Elias J Dayoub; Elena L Medvedeva; Sameed Ahmed M Khatana; Ashwin S Nathan; Andrew J Epstein; Peter W Groeneveld Journal: JAMA Netw Open Date: 2020-04-01